Prednisone

Prednisone is one of the most widely used systemic corticosteroids in clinical practice. It has a broad range of applications across primary care, emergency medicine, internal medicine, pulmonology, rheumatology, dermatology, nephrology, gastroenterology, haematology, oncology, and transplant medicine. In South Africa, prednisone remains a familiar and important medicine because it is relatively accessible, clinically versatile, and effective in controlling inflammation and immune-mediated disease.

Despite its usefulness, prednisone requires careful prescribing. Its benefits can be substantial, but inappropriate use, excessive duration, inadequate monitoring, or abrupt discontinuation may lead to significant harm. Healthcare professionals should approach prednisone as a medicine that can be highly effective when used with a clear indication, appropriate dosing, patient-specific risk assessment, and a defined review plan.

This article provides a professional overview of prednisone, with emphasis on South African clinical considerations, safe prescribing, patient counselling, adverse effects, monitoring, and risk reduction.

2. What Is Prednisone?

Prednisone is a synthetic glucocorticoid. It is classified as a systemic corticosteroid and is used primarily for its anti-inflammatory and immunosuppressive effects. Prednisone itself is a prodrug, meaning it must be converted in the liver to its active form, prednisolone.

Once converted, prednisolone acts on glucocorticoid receptors and influences the expression of multiple genes involved in inflammation and immune response. This results in reduced production of inflammatory mediators, suppression of immune cell activity, and decreased tissue swelling.

Prednisone should not be confused with anabolic steroids used for muscle building. Prednisone is a medical corticosteroid used to manage disease processes involving inflammation, immune activation, or adrenal hormone deficiency.

3. Mechanism of Action

3.1 Anti-inflammatory effects

Prednisone reduces inflammation by decreasing the production of substances such as prostaglandins, leukotrienes, cytokines, and other inflammatory mediators. It also reduces migration of inflammatory cells into affected tissues.

This explains its usefulness in conditions such as asthma exacerbations, inflammatory arthritis, dermatitis, inflammatory bowel disease, and autoimmune disorders.

3.2 Immunosuppressive effects

Prednisone suppresses several components of the immune system. It can reduce T-cell activity, alter cytokine signalling, and impair inflammatory responses. This is clinically useful in autoimmune disease, transplant medicine, and severe inflammatory disorders.

However, the same immunosuppressive effect increases susceptibility to infection and may mask typical signs of infection, such as fever, redness, and inflammatory pain.

3.3 Metabolic effects

Prednisone also affects carbohydrate, protein, and fat metabolism. It may increase blood glucose, promote protein breakdown, redistribute fat, and contribute to weight gain. These effects are especially important in patients with diabetes, obesity, hypertension, cardiovascular disease, or metabolic syndrome.

4. Common Clinical Uses

Prednisone has many clinical applications. The decision to use it should always be based on a clear diagnosis or working diagnosis, expected benefit, and risk profile.

4.1 Respiratory conditions

Prednisone is often used in acute exacerbations of asthma and chronic obstructive pulmonary disease when systemic corticosteroid therapy is indicated. In these settings, short courses may reduce airway inflammation, improve airflow, and reduce relapse risk.

In South Africa, respiratory prescribing should be especially attentive to tuberculosis risk. Chronic cough, weight loss, night sweats, haemoptysis, fever, or known TB exposure should prompt appropriate assessment before or during corticosteroid therapy.

4.2 Allergic and immunological conditions

Prednisone may be used for severe allergic reactions, urticaria, angioedema, or other hypersensitivity conditions when clinically appropriate. It is not a substitute for adrenaline in anaphylaxis but may be used as part of broader management after emergency stabilisation.

4.3 Rheumatological disease

Prednisone is commonly used in inflammatory rheumatological conditions, including rheumatoid arthritis, polymyalgia rheumatica, systemic lupus erythematosus, vasculitis, and other connective tissue diseases.

In these conditions, prednisone may be used as bridge therapy while disease-modifying treatment takes effect, or as part of induction therapy in severe disease. Long-term reliance on prednisone should generally be minimised where steroid-sparing therapy is available.

4.4 Dermatological disease

Severe inflammatory skin disorders may require systemic corticosteroids. Examples include severe eczema flares, autoimmune blistering diseases, severe drug reactions under specialist guidance, and other extensive inflammatory dermatoses.

Healthcare professionals should avoid casual or repeated prescribing for undiagnosed rashes, especially where infection, fungal disease, or drug reactions have not been adequately excluded.

4.5 Gastrointestinal disease

Prednisone may be used in inflammatory bowel disease flares, such as ulcerative colitis or Crohn’s disease, where systemic corticosteroid therapy is appropriate. It can help induce remission but is not suitable as long-term maintenance therapy.

Patients should be monitored for infection, gastrointestinal bleeding risk, mood changes, glucose elevation, and relapse after tapering.

4.6 Renal disease

Prednisone is used in selected renal conditions, including nephrotic syndrome and immune-mediated renal disease. These cases usually require careful monitoring of renal function, blood pressure, oedema, proteinuria, and infection risk.

4.7 Haematological conditions

Prednisone may be used in immune thrombocytopenia, autoimmune haemolytic anaemia, and selected haematological malignancy protocols. Monitoring should include blood counts, bleeding risk, infection risk, glucose, and treatment response.

4.8 Transplant medicine

Prednisone may form part of immunosuppressive regimens in organ transplantation. In this context, it is usually prescribed and monitored by specialist teams because of the complexity of infection prevention, drug interactions, rejection risk, and long-term metabolic complications.

5. South African Clinical Considerations

5.1 Tuberculosis risk

Tuberculosis remains an important consideration in South African healthcare. Systemic corticosteroids can worsen unrecognised infection, alter clinical presentation, and increase the risk of reactivation in vulnerable individuals.

Before starting prednisone, clinicians should consider TB symptoms and risk factors, including:

Persistent cough
Night sweats
Unexplained weight loss
Fever
Haemoptysis
Previous TB
Close contact with a person with TB
HIV infection or other immunosuppression

Where suspicion exists, appropriate investigation should not be delayed.

5.2 HIV and immunosuppression

South Africa has a significant population of people living with HIV. Prednisone may be used safely in many patients with HIV when clinically indicated, but the prescriber should consider immune status, current antiretroviral therapy, opportunistic infection risk, and possible drug interactions.

In patients with advanced immunosuppression, unexplained systemic symptoms, or suspected opportunistic infection, systemic corticosteroids should be used with caution and preferably with specialist input.

5.3 Diabetes and metabolic disease

Prednisone can increase blood glucose and may precipitate hyperglycaemia in patients with known or previously undiagnosed diabetes. This is especially relevant in South Africa, where diabetes and hypertension are common chronic conditions.

Patients with diabetes may require increased glucose monitoring and temporary adjustment of antidiabetic therapy. Healthcare professionals should warn patients about symptoms of hyperglycaemia, including excessive thirst, frequent urination, blurred vision, fatigue, and unexplained weight changes.

5.4 Hypertension and cardiovascular disease

Prednisone may cause fluid retention, increase blood pressure, and worsen heart failure in susceptible patients. Baseline cardiovascular risk assessment is important, especially in older adults and patients with established hypertension, renal disease, or cardiac disease.

5.5 Access to follow-up

In some South African settings, patients may have difficulty returning for follow-up because of transport costs, distance from facilities, work commitments, or overloaded clinics. For this reason, prednisone prescriptions should be clear, practical, and safe.

Written instructions are particularly important when tapering is required. The patient should know the dose, duration, when to return, and which symptoms require urgent care.

6. Pre-prescribing Assessment

Before prescribing prednisone, healthcare professionals should ask several practical questions.

6.1 Is there a clear indication?

Prednisone should not be used simply because symptoms are severe or non-specific. A clear indication should be documented, even if the diagnosis is provisional.

Examples of poor prescribing practice include repeated short courses for undiagnosed pain, chronic fatigue, non-specific rash, or cough without appropriate investigation.

6.2 Is infection present?

Systemic corticosteroids may worsen bacterial, viral, fungal, parasitic, or mycobacterial infections. They may also reduce the usual inflammatory signs that help clinicians recognise infection.

If infection is suspected, clinicians should decide whether prednisone is appropriate, whether antimicrobial therapy is required, and whether further investigation is necessary.

6.3 What comorbidities increase risk?

Important comorbidities include:

Diabetes
Hypertension
Heart failure
Chronic kidney disease
Liver disease
Peptic ulcer disease
Osteoporosis
Glaucoma
Cataracts
Psychiatric illness
Seizure disorders
Previous TB
HIV infection
Current pregnancy or breastfeeding

6.4 What other medicines is the patient taking?

A medication review should include prescription medicines, over-the-counter medicines, herbal products, traditional medicines, and intermittent use of analgesics or anti-inflammatory drugs.

Particular attention should be paid to NSAIDs, anticoagulants, antidiabetic medicines, diuretics, antiepileptic medicines, rifampicin, antiretrovirals, vaccines, and other immunosuppressive agents.

7. Dosing Principles

Prednisone dosing depends on the indication, severity, patient weight, comorbidities, and response to treatment. A single standard dose is not appropriate for all patients.

7.1 Use the lowest effective dose

The goal is to achieve adequate disease control while minimising adverse effects. Higher doses may be necessary in severe disease, but they should be reviewed frequently.

7.2 Use the shortest appropriate duration

Short courses may be sufficient for many acute indications. Longer courses should have a documented plan, including review dates and tapering strategy.

7.3 Consider morning dosing

Morning dosing is often preferred because it aligns more closely with the body’s normal cortisol rhythm and may reduce sleep disturbance. However, some conditions or specialist protocols may require different dosing schedules.

7.4 Individualise therapy

Dosing must be individualised. Frail older adults, children, pregnant patients, patients with diabetes, and patients with infection risk may need closer monitoring or alternative approaches.

8. Tapering and Discontinuation

8.1 Why tapering matters

Abrupt discontinuation after prolonged corticosteroid therapy can cause adrenal insufficiency or recurrence of the underlying disease. The hypothalamic-pituitary-adrenal axis may be suppressed, reducing the body’s ability to produce sufficient cortisol during stress.

8.2 Symptoms of withdrawal or adrenal insufficiency

Symptoms may include:

Severe fatigue
Weakness
Nausea or vomiting
Dizziness
Low blood pressure
Joint or muscle pain
Fever
Headache
Mood changes
Return of the original disease symptoms

8.3 Tapering approach

Tapering should be based on treatment duration, dose, clinical response, and the condition being treated. Patients should receive clear instructions and should not be expected to design their own taper.

For complex cases, specialist input may be appropriate, especially after long-term use, high-dose therapy, recurrent courses, or suspected adrenal suppression.

9. Adverse Effects

Prednisone adverse effects are related to dose, duration, patient risk factors, and cumulative exposure. Even short courses may cause insomnia, mood changes, increased appetite, dyspepsia, or glucose elevation. Longer exposure increases the risk of metabolic, musculoskeletal, ocular, endocrine, and infectious complications.

9.1 Metabolic effects

Prednisone may cause:

Increased appetite
Weight gain
Hyperglycaemia
Worsening diabetes
Fat redistribution
Dyslipidaemia with prolonged use

Patients with diabetes should be given specific advice about glucose monitoring and when to seek care.

9.2 Cardiovascular and renal effects

Prednisone may contribute to:

Fluid retention
Peripheral oedema
Increased blood pressure
Worsening heart failure
Electrolyte disturbances in some patients

Patients with hypertension, renal disease, or cardiac disease should be monitored carefully.

9.3 Gastrointestinal effects

Prednisone can cause dyspepsia, gastritis, and increased risk of gastrointestinal bleeding, especially when combined with NSAIDs or anticoagulants.

Patients should be advised to report severe abdominal pain, vomiting blood, black stools, or unexplained weakness.

9.4 Neuropsychiatric effects

Mood and behavioural changes are clinically important and sometimes under-recognised. Prednisone may cause:

Insomnia
Irritability
Anxiety
Low mood
Euphoria
Mania
Psychosis
Suicidal thoughts in rare cases

Patients with previous psychiatric illness should be monitored closely. Family members may notice behavioural changes before the patient does.

9.5 Musculoskeletal effects

Long-term prednisone use may lead to:

Osteoporosis
Increased fracture risk
Muscle weakness
Steroid myopathy
Avascular necrosis in some cases

Bone protection should be considered for patients requiring prolonged therapy, especially older adults, postmenopausal women, and those with previous fractures or other osteoporosis risk factors.

9.6 Skin and wound effects

Prednisone may cause:

Skin thinning
Easy bruising
Acne
Striae
Delayed wound healing
Increased susceptibility to skin infections

These effects are more common with prolonged or repeated exposure.

9.7 Ocular effects

Long-term corticosteroid exposure may increase the risk of cataracts and glaucoma. Patients on prolonged therapy should be asked about visual symptoms and referred for eye assessment where appropriate.

9.8 Endocrine effects

Prednisone may suppress the hypothalamic-pituitary-adrenal axis. Long-term therapy may also cause Cushingoid features, menstrual irregularities, and growth suppression in children.

10. Monitoring During Therapy

Monitoring should be tailored to the expected duration and risk level.

10.1 Short-course therapy

For short courses, monitoring may focus on counselling, symptom improvement, and safety-netting. Patients should understand what to expect and when to seek help.

10.2 Medium- to long-term therapy

For longer courses or repeated courses, consider monitoring:

Blood pressure
Weight
Oedema
Blood glucose
Mood and sleep
Infection symptoms
Gastrointestinal symptoms
Bone health
Eye symptoms
Muscle strength
Growth in children
Treatment adherence
Need for tapering

10.3 Documentation

Good documentation should include:

Indication
Starting dose
Expected duration
Review date
Tapering plan, if relevant
Counselling provided
Monitoring plan
Patient-specific risks

11. Drug Interactions and Practical Cautions

Prednisone can interact with several medicine classes or increase risk when used with them.

11.1 NSAIDs

Combining prednisone with NSAIDs may increase gastrointestinal bleeding risk. This is especially important in patients using ibuprofen, diclofenac, naproxen, aspirin, or over-the-counter pain medicines.

11.2 Anticoagulants

Patients on anticoagulants require careful monitoring because corticosteroids may alter bleeding risk or interact indirectly through changes in metabolism, illness, or gastrointestinal effects.

11.3 Antidiabetic medicines

Prednisone may increase blood glucose and reduce glycaemic control. Patients using insulin or oral antidiabetic medicines may require closer monitoring and dose adjustment.

11.4 Rifampicin and tuberculosis treatment

Rifampicin can affect corticosteroid metabolism. This is particularly relevant in South Africa because rifampicin is commonly used in TB treatment regimens. Specialist or experienced clinician input may be required when managing patients on both medicines.

11.5 Vaccines

Live vaccines may be inappropriate in patients receiving immunosuppressive doses of systemic corticosteroids. Vaccination history and future vaccination plans should be reviewed where longer-term therapy is expected.

11.6 Traditional and complementary medicines

Patients may not volunteer the use of traditional or herbal medicines unless specifically asked. Healthcare professionals should ask respectfully and non-judgementally, as some products may affect liver enzymes, bleeding risk, blood pressure, glucose, or adherence to prescribed medicines.

12. Patient Counselling

Effective counselling is essential. Many complications can be reduced when patients understand why prednisone is prescribed, how to take it, and what warning signs to look for.

12.1 Key counselling messages

Patients should be told:

Take prednisone exactly as prescribed.
Do not stop suddenly unless instructed.
Do not share the medicine with anyone else.
Take it with food if it irritates the stomach.
Avoid taking extra doses unless advised.
Keep all follow-up appointments.
Inform any healthcare provider that they are taking prednisone.
Report signs of infection or serious side effects promptly.

12.2 Counselling for tapering

If tapering is needed, instructions should be written clearly. For example, the prescription should not simply say “taper as directed” unless the patient has a written schedule.

Patients should understand that tapering is not optional and that stopping suddenly may be dangerous.

12.3 Counselling for diabetes

Patients with diabetes should be advised that prednisone may raise glucose levels. They should know how often to check glucose, what readings require action, and when to contact a clinic or doctor.

12.4 Counselling for infection risk

Patients should seek care for fever, worsening cough, painful urination, skin infection, shortness of breath, TB symptoms, or feeling unusually unwell.

In South Africa, cough lasting more than two weeks, night sweats, unexplained weight loss, fever, or coughing blood should prompt TB assessment.

13. Red Flags Requiring Urgent Review

Urgent medical review is required if a patient develops:

13.1 Allergic or severe hypersensitivity symptoms

Facial swelling
Lip, tongue, or throat swelling
Severe rash
Wheezing
Difficulty breathing
Collapse

13.2 Gastrointestinal warning signs

Vomiting blood
Black stools
Severe abdominal pain
Persistent vomiting
Sudden weakness with possible bleeding

13.3 Severe infection symptoms

High fever
Confusion
Severe weakness
Rapid breathing
Worsening cough
Suspected TB symptoms
Sepsis features

13.4 Psychiatric emergencies

Severe agitation
Mania
Hallucinations
Severe depression
Suicidal thoughts
Dangerous behaviour

13.5 Possible adrenal crisis

Collapse
Severe weakness
Low blood pressure
Vomiting
Confusion
Symptoms after abruptly stopping prednisone

14. Storage, Handling, and Disposal

Prednisone should be stored safely and kept out of reach of children. Patients should be advised to keep tablets in the original packaging, away from heat, moisture, and direct sunlight.

Expired or unused prednisone should be returned to a pharmacy for safe disposal. Patients should be discouraged from throwing medicines into toilets, drains, or household waste.

15. Professional Risk-Reduction Strategies

15.1 Prescribe deliberately

Every prednisone prescription should have a clear reason. Avoid automatic repeat prescribing without reassessment.

15.2 Limit duration where possible

Short courses should not become repeated or chronic therapy without a diagnosis and review plan.

15.3 Use steroid-sparing approaches

Where available and appropriate, consider steroid-sparing medicines or non-pharmacological strategies to reduce cumulative corticosteroid exposure.

15.4 Communicate clearly

Patients should leave the consultation knowing:

Why they are taking prednisone
How much to take
When to take it
How long to take it
Whether they must taper
Which symptoms require urgent care

15.5 Review vulnerable patients carefully

Higher-risk patients include children, older adults, pregnant patients, patients with diabetes, patients with previous TB, patients with HIV, patients with psychiatric illness, and those with poor access to follow-up.

16. Use in Special Populations

16.1 Children

Children receiving systemic corticosteroids require careful dosing, growth monitoring, and review of cumulative exposure. Repeated or prolonged courses may affect growth and increase infection risk.

16.2 Older adults

Older adults are more vulnerable to hypertension, diabetes complications, delirium, osteoporosis, cataracts, glaucoma, infection, and drug interactions. Lower effective doses and close monitoring are often appropriate.

16.3 Pregnancy and breastfeeding

Prednisone may be used in pregnancy or breastfeeding when the expected benefit outweighs the risk, but this decision should be individualised. The underlying condition, dose, duration, and available alternatives should be considered.

16.4 Patients with psychiatric history

Patients with a history of depression, bipolar disorder, psychosis, severe anxiety, or previous steroid-induced psychiatric symptoms need careful counselling and monitoring. Family or caregiver involvement may be helpful where appropriate.

17. Practical Prescribing Checklist

Before prescribing prednisone, healthcare professionals may consider the following checklist:

17.1 Before starting

Confirm indication.
Assess infection risk.
Screen for TB symptoms where relevant.
Review HIV status or immunosuppression where clinically appropriate.
Check diabetes and blood pressure history.
Review gastrointestinal bleeding risk.
Ask about psychiatric history.
Review current medicines.
Consider pregnancy or breastfeeding.
Decide dose and duration.
Decide whether tapering is needed.

17.2 During treatment

Assess symptom response.
Monitor adverse effects.
Check blood pressure and glucose where indicated.
Look for infection.
Review adherence.
Adjust dose if necessary.
Reinforce counselling.

17.3 At stopping

Taper when appropriate.
Watch for relapse.
Watch for adrenal insufficiency symptoms.
Document final plan.
Arrange review if symptoms recur.

18. Conclusion

Prednisone is a valuable systemic corticosteroid with a major role in the management of inflammatory, allergic, autoimmune, respiratory, renal, gastrointestinal, haematological, dermatological, and transplant-related conditions. In South Africa, its use requires careful attention to local clinical realities, including tuberculosis, HIV, diabetes, hypertension, variable access to follow-up, and the need for clear patient communication.

For healthcare professionals, safe prednisone prescribing involves more than selecting a dose. It requires a structured approach: confirm the indication, assess patient-specific risk, prescribe the lowest effective dose for the shortest appropriate duration, monitor for adverse effects, provide clear counselling, and taper when necessary.

When used thoughtfully, prednisone can produce rapid and meaningful clinical benefit. When used casually or without adequate monitoring, it can contribute to serious complications. The professional responsibility is therefore to use prednisone with precision, caution, and clear communication.